NCT00752999View on ClinicalTrials.gov

Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

March 31, 2010

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Fostamatinib Disodium (R935788)

150 mg tablet, oral, twice-a-day

DRUG

Placebo

Placebo tablet, oral, twice-a-day

Sponsors
All Listed Sponsors
lead

Rigel Pharmaceuticals

INDUSTRY